Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,477,611
  • Shares Outstanding, K 129,388
  • Annual Sales, $ 660,570 K
  • Annual Income, $ -78,730 K
  • EBIT $ -121 M
  • EBITDA $ -45 M
  • 60-Month Beta 1.58
  • Price/Sales 2.04
  • Price/Cash Flow 25.69
  • Price/Book 1.74

Options Overview Details

View History
  • Implied Volatility 73.69% (-83.51%)
  • Historical Volatility 41.55%
  • IV Percentile 71%
  • IV Rank 27.59%
  • IV High 158.32% on 02/04/26
  • IV Low 41.44% on 08/15/25
  • Expected Move (DTE 11) 1.09 (9.59%)
  • Put/Call Vol Ratio 0.71
  • Today's Volume 48
  • Volume Avg (30-Day) 233
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 16,419
  • Open Int (30-Day) 17,460
  • Expected Range 10.26 to 12.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.05
  • Number of Estimates 4
  • High Estimate -0.03
  • Low Estimate -0.07
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.16 +1.70%
on 02/06/26
13.74 -17.39%
on 01/12/26
-1.81 (-13.75%)
since 01/09/26
3-Month
9.71 +16.89%
on 11/14/25
13.74 -17.39%
on 01/12/26
+1.27 (+12.60%)
since 11/07/25
52-Week
4.72 +140.47%
on 08/01/25
14.73 -22.95%
on 02/14/25
-2.10 (-15.61%)
since 02/07/25

Most Recent Stories

More News
1 Stock Under $50 Worth Your Attention and 2 We Brush Off

1 Stock Under $50 Worth Your Attention and 2 We Brush Off

CHWY : 27.39 (-2.25%)
ALHC : 20.76 (-4.55%)
NEO : 11.35 (-0.61%)
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its fourth quarter and full year 2025 financial...

NEO : 11.35 (-0.61%)
3 Cash-Burning Stocks with Warning Signs

3 Cash-Burning Stocks with Warning Signs

BLNK : 0.7102 (+1.15%)
NEO : 11.35 (-0.61%)
SATS : 115.19 (+3.21%)
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

– Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 million – – Announces Chief Financial...

NEO : 11.35 (-0.61%)
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the upcoming 44 th Annual...

NEO : 11.35 (-0.61%)
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics and lab services industry veteran...

NEO : 11.35 (-0.61%)
3 Russell 2000 Stocks We Think Twice About

3 Russell 2000 Stocks We Think Twice About

FWRG : 17.40 (-0.80%)
EAT : 171.21 (+1.35%)
NEO : 11.35 (-0.61%)
3 Stocks Under $50 We Steer Clear Of

3 Stocks Under $50 We Steer Clear Of

NEO : 11.35 (-0.61%)
HPE : 23.91 (+1.27%)
KEY : 23.01 (-0.86%)
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation

NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026

NEO : 11.35 (-0.61%)
NeoGenomics to Present New ctDNA Research at SABCS 2025

Data include findings generated using the RaDaR 1.0 assay to assess molecular residual disease and recurrence risk in early breast cancer

NEO : 11.35 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 11.75
2nd Resistance Point 11.61
1st Resistance Point 11.48
Last Price 11.35
1st Support Level 11.21
2nd Support Level 11.07
3rd Support Level 10.94

See More

52-Week High 14.73
Last Price 11.35
Fibonacci 61.8% 10.91
Fibonacci 50% 9.72
Fibonacci 38.2% 8.54
52-Week Low 4.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar